Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00094692 · ClinicalTrials.gov registry record · Phase 3
An Evaluation of Treatment of Amblyopia in Children 7 To <18 Years Old
A Phase 3 study, sponsored by Jaeb Center for Health Research.
- Completed
- Registry status
- Phase 3
- Development phase
- 507
- Enrollment target
NCT00094692 is a Phase 3 study that has completed, run by Jaeb Center for Health Research. The registered enrollment target is 507 participants.
The verdict
NCT00094692, a Phase 3 study, has completed, sponsored by Jaeb Center for Health Research.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 507 participants
- Enrollment target
Study Summary
The goals of this study are: * To determine the response rate of treatment of amblyopia in 7 to \<18 year olds. * To determine the frequency of recurrence of amblyopia in 7 to \<18 year olds after discontinuation of amblyopia treatment.
Interventions
- DEVICE Eye patch
- DEVICE spectacles
- DRUG atropine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 507 participants |
| Start Date | 2002-10 |
| Est. Completion | 2005-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00094692
The ClinicalTrials.gov registry entry for NCT00094692 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 507 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jaeb Center for Health Research, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Eye patch is the first listed.
NCT00094692 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00094692 about?
NCT00094692 is a clinical study titled "An Evaluation of Treatment of Amblyopia in Children 7 To <18 Years Old". The goals of this study are: * To determine the response rate of treatment of amblyopia in 7 to \<18 year olds. * To determine the frequency of recurrence of amblyopia in 7 to \<18 year olds after discontinuation of amblyopia treatment.
What is the current status of trial NCT00094692?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 507 participants. The study started on 2002-10. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00094692?
The interventions under investigation include: Eye patch (DEVICE), spectacles (DEVICE), atropine (DRUG).
Who is sponsoring clinical trial NCT00094692?
This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.